We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A generic version of the antiplatelet drug Plavix will go on sale throughout the European Union (EU) by the end of June, the Swiss pharmaceutical company Schweizerhall said.